BiomX Inc. (PHGE)
NYSEAMERICAN: PHGE · Real-Time Price · USD
0.396
+0.001 (0.15%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Company Description
BiomX Inc., a holding company, focuses on defense, security, and critical infrastructure technologies.
The company’s portfolio targets various niches, such as counter‑drone systems, AI-enabled command-and-control, perimeter and border security, wide-area surveillance, and aerial firefighting.
It serves defense agencies, prime contractors, transportation operators, municipalities, and critical infrastructure providers.
The company was founded in 2015 and is based in Dover, Delaware.
BiomX Inc.
| Country | United States |
| Founded | 2015 |
| Industry | Aerospace & Defense |
| Sector | Industrials |
| Employees | 20 |
| CEO | Michael Oster |
Contact Details
Address: 850 New Burton Road, Suite 201 Dover, Delaware 19904 United States | |
| Website | biomx.com |
Stock Details
| Ticker Symbol | PHGE |
| Exchange | NYSEAMERICAN |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001739174 |
| CUSIP Number | 09090D103 |
| ISIN Number | US09090D5095 |
| Employer ID | 82-3364020 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Michael Oster | Chief Executive Officer and Director |
| Marina Wolfson CPA | Secretary |
| Prof. Rotem Sorek Ph.D. | Scientific Founder |
| Dr. Eran Elinav M.D., Ph.D. | Scientific Founder |
| Dr. Timothy K. Lu M.D., Ph.D. | Scientific Founder |
| Dr. Carl R. Merril M.D. | Scientific Founder |
| David Rokach | Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer |
| Roy Timor-Rousso | Chief Business Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 26, 2026 | 8-K | Current Report |
| Jun 22, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Jun 18, 2026 | 8-K | Current Report |
| Jun 16, 2026 | SCHEDULE 13D/A | Filing |
| Jun 16, 2026 | 424B5 | Filing |
| Jun 12, 2026 | 8-K | Current Report |
| Jun 12, 2026 | 8-K/A | [Amend] Current report |
| Jun 8, 2026 | DEF 14A | Other definitive proxy statements |
| Jun 5, 2026 | 8-K | Current Report |
| May 28, 2026 | SCHEDULE 13D/A | Filing |